Original Research

Bevacizumab is an Efficient Therapeutic Approach with Low Side Effects in Patient-Derived Xenografts of Adenoid Cystic Carcinoma of the Lacrimal Gland

Zhang J, Yan X, Liu R, Wu S, Liu Q, Li J, Ma J

Cancer Management and Research 2022, 14:1023-1032

Published Date: 6 March 2022